Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jannsen Biotech Inc. maintains a highly focused prosecution profile with 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This single matter is assigned to 1 distinct examiner and 1 distinct art unit, reflecting a concentrated point of contact within the USPTO. The narrow scope of this activity suggests a specific, targeted effort within the broader mechanical engineering field. By operating within a single art unit, the company's current intellectual property is subject to a very specific set of examination guidelines and technical standards.
The examiner DIOP, FATIMATA SAHRA is identified as the busiest examiner, holding 1 pending office action. This individual represents the entirety of the current pending workload for the company. For practitioners, this means that the outcome of the current portfolio activity depends entirely on the specific examination style and requirements of this one examiner. The alignment of the pending action with the art unit indicates that the prosecution is currently confined to a single technical niche. This lack of diversification across examiners or units means that any delays or specific interpretations by DIOP, FATIMATA SAHRA will directly impact the company's immediate patent goals.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIOP, FATIMATA SAHRA | 1 | 68.6% | +38.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17286987 | Drug Delivery Devices and Systems for Local Drug Delivery to the Upper Urinary Tract | DIOP, FATIMATA SAHRA | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17286987 | Drug Delivery Devices and Systems for Local Drug Delivery to the Upper Urinary Tract | DIOP, FATIMATA SAHRA | 3783 | §103 | Non-Final OA | — | Pending | Apr 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial